Anti-malarial Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Anti-malarial Drugs Market Overview
The Global "Anti-Malarial Drugs Market" is estimated to reach at a high CAGR during the forecast period (2022-2031).
Malaria is an infectious disease, which spreads through a bite of an infected female Anopheles mosquito, transferring parasites into the human body. Merozoites grow inside the red cells and destroy them, which further cause symptoms such as fever, tiredness, vomiting, and headache. The drugs that are used to treat and prevent malarial infections are called antimalarial.
Anti-malarial Drugs Market Dynamics
The market is predicted to grow due to increased research for novel medications and new combination therapies.
The different levels of the innovation system of antimalarial therapies in Nigeria and Burkina Faso are identified. The innovation systems approach explores the readiness of African countries for a transition to TACTs. The innovation systems approach assumes that integrating new technology in society is a collective effort in a complex social system. Triple artemisinin-based combination therapies (TACTs) are being developed to respond to artemisinin and partner drug resistance in the treatment of falciparum malaria in Southeast Asia. In African countries, where current artemisinin-based combination therapies (ACTs) are still effective, TACTs can benefit the larger community and future patients by mitigating the risk of drug resistance. This approach has become a well-established analytical tool in transition studies to generate insight into innovation barriers and define policy implications accordingly.
Side effects associated with anti-malaria drugs are expected to hamper market growth.
Most anti-malarial drugs are associated with severe side effects, which is expected to decrease demand for these drugs. For instance, Hydroxychloroquine main side effects are gastrointestinal upset (vomiting, diarrhea, stomach cramps), skin rash, headache, dizziness, and ocular toxicity. However, serious side effects, including arrhythmia, bronchospasm, angioedema, and seizures, rarely occur. Such factors are expected to hamper the market growth.
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian